跳至主要内容
临床试验/NCT04516694
NCT04516694已完成不适用

Promoting Adolescent Investment In Diabetes Care

Harvard Pilgrim Health Care2 个研究点 分布在 1 个国家目标入组 39 人开始时间: 2020年9月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
39
试验地点
2
主要终点
HbA1c

研究概览

简要总结

Two financial incentive strategies targeting adolescents with type 1 diabetes will be compared to usual care for motivating adolescents to engage in improved self-care to manage their diabetes.

详细描述

Participants will be asked to choose a self-care goal relevant to the device(s) they use to manage their diabetes from a pre-defined list of self-care targets. A randomized 3 (treatment) x 3 (occasion) crossover design will be used to compare treatments that are administered to participants in a predetermined sequence. The intervention arms include financial incentives administered in a gain- and loss-frame for adherence to daily self-care goals. The control arm is usual care. Participants can also earn additional incentives for meeting clinical care goals such as an improvement in the percentage of time glucose levels are consistent with hyperglycemia (>180 mg/dL). The primary outcome will be HbA1c at 12 weeks compared to baseline. Secondary outcomes will include frequency of insulin administration, engagement in diabetes self-care (SCI-R), patient-reported outcomes (Problem Areas in Diabetes - Teen version and Diabetes Family Conflict Scale).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
12 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • >12 and ≤18 years old
  • Diagnosed with type 1 diabetes ≥12 months
  • Speaks English fluently
  • Cognitively able to participate in incentive program and complete surveys.
  • Have access to a mobile phone to receive goal-obtainment and incentive updates
  • Receives diabetes-related clinical care from Seattle Children's Hospital Diabetes Clinic
  • Have the ability to upload medical data remotely from home per usual care processes employed by Seattle Children's Hospital Diabetes Clinics

排除标准

  • Patient is already participating in another research study to improve diabetes self-care and/or glycemic control
  • Baseline daily average glucose checks are greater than 4 checks per day OR baseline daily CGM active wear is greater than 70% of the time AND baseline average insulin bolus score is greater than 3 times a day OR they do not use an insulin pump (or are unwilling to use a smart insulin pen)
  • Patient refusal to participate (any age), or caregiver refusal to participate for patients less than 18 years of age
  • Cognitively or physically unable to participate
  • Patient is unable to speak in the English language
  • Patient is unable to read in the English language
  • Patient is a ward of the state
  • Patient has severe comorbidities including other major chronic health conditions that significantly impact daily management demands or health outcomes

结局指标

主要结局

HbA1c

时间窗: 12 weeks

Change in HbA1c from baseline to 12 weeks

次要结局

  • Time in Range(12 weeks)
  • Insulin Administration(12 weeks)
  • PAID-T(12 weeks)
  • DFCS(12 weeks)
  • Glucose monitoring(12 weeks)
  • SCI-R(12 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Davene R. Wright

Faculty

Harvard Pilgrim Health Care

研究点 (2)

Loading locations...

相似试验